lestaurtinib has been researched along with liphagal in 1 studies
Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (liphagal) | Trials (liphagal) | Recent Studies (post-2010) (liphagal) |
---|---|---|---|---|---|
124 | 12 | 63 | 14 | 0 | 10 |
Protein | Taxonomy | lestaurtinib (IC50) | liphagal (IC50) |
---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.1 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bharate, SB; Sawant, SD; Singh, PP; Vishwakarma, RA | 1 |
1 review(s) available for lestaurtinib and liphagal
Article | Year |
---|---|
Kinase inhibitors of marine origin.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Aquatic Organisms; Aza Compounds; Carbazoles; Chemistry, Pharmaceutical; Depsipeptides; Furans; Humans; Indoles; Naphthyridines; Peptides, Cyclic; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Pyrimidines; Staurosporine; Terpenes | 2013 |